These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3213122)

  • 1. [The status of prazosin in therapy of chronic heart failure].
    Urbaszek W; Graf B; Bölter C; Zingler C; Mekat A; Nabel HJ; Ernst B
    Z Gesamte Inn Med; 1988 Nov; 43(21):601-4. PubMed ID: 3213122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can prazosin be used in the treatment of refractory heart failure only on the basis of clinical monitoring?
    Nikolić V; Planinc D; Rudar M; Pagon L
    Wien Med Wochenschr; 1987 Jan; 137(1):9-13. PubMed ID: 3590814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of chronic heart failure with vasodilators].
    Urbaszek W; Graf B
    Z Gesamte Inn Med; 1986 Feb; 41(3):75-80. PubMed ID: 2870591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
    Tomov I; Kaloianova A; Terzieva L; Nikolov G; Elenkova A
    Vutr Boles; 1982; 21(6):45-50. PubMed ID: 6761964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
    Tomov I; Kaloianova A; Terzieva L; Elenkova A; Nikolov G
    Vutr Boles; 1981; 20(6):72-8. PubMed ID: 7039130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of peripheral vasodilators with different mechanisms of action in treating heart failure patients].
    Novikov SV; Mareev VIu; Elizarova NA; Naumov VG; Sazonova LN
    Ter Arkh; 1987; 59(9):126-30. PubMed ID: 3424177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of acute and chronic vasodilator administration on hemodynamics and catecholamine concentration in chronic left heart failure (author's transl)].
    Klein W; Goebel R
    Z Kardiol; 1980 Feb; 69(2):120-5. PubMed ID: 6779433
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydralazine in heart failure.
    Chatterjee K
    Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 12. Vasodilator therapy in children: acute and chronic effects in children with left ventricular dysfunction or mitral regurgitation.
    Beekman RH; Rocchini AP; Dick M; Crowley DC; Rosenthal A
    Pediatrics; 1984 Jan; 73(1):43-51. PubMed ID: 6361679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of heart failure with vasodilators].
    Bolte HD
    Internist (Berl); 1980 Dec; 21(12):753-9. PubMed ID: 6451599
    [No Abstract]   [Full Text] [Related]  

  • 14. [Short- and medium-term hemodynamic effects of prazosin in chronic refractory cardiac failure].
    Gillard C; Boland J; Calay G
    Arch Mal Coeur Vaiss; 1982 Apr; 75(4):469-77. PubMed ID: 6808956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
    Reifart N; Schmidt-Moritz AD; Nadj M; Kaltenbach M; Bussmann WD
    Z Kardiol; 1985 Apr; 74(4):205-12. PubMed ID: 3923726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic possibilities in terminal heart failure].
    Urbaszek W
    Z Gesamte Inn Med; 1988 Oct; 43(19):533-9. PubMed ID: 2905554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alpha receptor blocking and cardial insufficiency].
    Klein W
    Wien Med Wochenschr; 1982; 132 Spec No():6-9. PubMed ID: 6123199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
    Honda T; Hiramori K; Haze K; Saito M; Fuseno H; Fukami K; Umemoto M; Tanaka N; Ikeda M
    Kokyu To Junkan; 1981 May; 29(5):527-35. PubMed ID: 7313357
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term results of vasodilator therapy with prazosin in severe refractory cardiac insufficiency].
    Bertel O; Burkart F
    Ther Umsch; 1981; 38 Suppl():45-8. PubMed ID: 7339916
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.